IP Library Granted Patent US 9,611,458
Granted Patent B2
US 9,611,458 · App. 13/976,524 · Granted Apr 4, 2017

Method for preparing aqueous solution containing culture medium and chelating agent

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,611,458
App. No.
13/976,524
Granted
Apr 4, 2017
Kind
B2
Abstract

Provided are a method for preparing a highly versatile aqueous solution having remarkably improved membrane filterability, which can be stably membrane-filtered in a short time, an aqueous solution prepared by the preparation method, a method for culturing cells using the aqueous solution which is prepared by the preparation method, a method for producing a physiologically active substance using the culturing method, a physiologically active substance produced by the method for producing a physiologically active substance, a method for performing membrane filtration of the aqueous solution which is prepared by the preparation method of the aqueous solution, a method for improving membrane filterability of the aqueous solution, and a method for producing the physiologically active substance by preparing the aqueous solution, performing membrane filtration of the aqueous solution, and then culturing cells using the resulting aqueous solution. The present invention relates to a method for preparing an aqueous solution, characterized by addition of a chelating agent.

Claims (32)

1. A method for preparing an aqueous solution comprising a powdered culture medium and a chelating agent, comprising adding the chelating agent to water prior to the final pH adjustment of the aqueous solution,

wherein the powdered culture medium is a culture medium for animal cells,

the chelating agent is added before addition of the powdered culture medium or simultaneously together with the powdered culture medium, and

a concentration of the chelating agent is 0.1 to 100 mmol/L.

2. The method for preparing an aqueous solution according to claim 1 , wherein the powdered culture medium is a culture medium for Chinese hamster ovary tissue-derived CHO cells.

3. The method for preparing an aqueous solution according to claim 1 , wherein the chelating agent is one or more selected from citric acid, malic acid, ethylenediaminetetraacetic acid, ethylenediaminetetraacetic acid iron(III) sodium salt, sialic acid, and salts or hydrates thereof.

4. A method for culturing cells comprising culturing the cells in an aqueous solution comprising a powdered culture medium and a chelating agent,

wherein the aqueous solution is prepared by adding the chelating agent to water prior to the final pH adjustment of the aqueous solution,

the cells are animal cells,

the chelating agent is added before addition of the powdered culture medium or simultaneously together with the powdered culture medium, and

a concentration of the chelating agent is 0.1 to 100 mmol/L.

5. The method for culturing cells according to claim 4 , wherein the animal cells are Chinese hamster ovary tissue-derived CHO cells.

6. The method for culturing cells according to claim 4 , wherein the chelating agent is one or more selected from citric acid, malic acid, ethylenediaminetetraacetic acid, ethylenediaminetetraacetic acid iron(III) sodium salt, sialic acid, and salts or hydrates thereof.

7. A method for producing a physiologically active substance comprising culturing cells in an aqueous solution to produce the physiologically active substance and isolating the physiologically active substance,

wherein the aqueous solution comprises a powdered culture medium and a chelating agent and is prepared by adding the chelating agent to water prior to the final pH adjustment of the aqueous solution,

the physiologically active substance is a peptide or a protein,

the chelating agent is added before addition of the powdered culture medium or simultaneously together with the powdered culture medium, and

a concentration of the chelating agent is 0.1 to 100 mmol/L.

8. The method for producing a physiologically active substance according to claim 7 , wherein the protein is a glycoprotein or an antibody.

9. The method for producing a physiologically active substance according to claim 7 , wherein the chelating agent is one or more selected from citric acid, malic acid, ethylenediaminetetraacetic acid, ethylenediaminetetraacetic acid iron(III) sodium salt, sialic acid, and salts or hydrates thereof.

10. A method for performing membrane-filtration of an aqueous solution comprising a powdered culture medium and a chelating agent, said method comprising performing membrane-filtration of the aqueous solution,

wherein the aqueous solution is prepared by adding a chelating agent prior to the final pH adjustment of the aqueous solution,

the chelating agent is added before addition of the powdered culture medium or simultaneously together with the powdered culture medium, and

a concentration of the chelating agent is 0.1 to 100 mmol/L.

11. The method for performing membrane-filtration according to claim 10 , wherein the chelating agent is one or more selected from citric acid, malic acid, ethylenediaminetetraacetic acid, ethylenediaminetetraacetic acid iron(III) sodium salt, sialic acid, and salts or hydrates thereof.

12. The method for performing membrane-filtration according to claim 10 , wherein the powdered culture medium further includes one or more selected from metal salts, sugars, and vitamins.

13. The method for performing membrane-filtration according to claim 10 , wherein the powdered culture medium is a culture medium for cell culture.

14. The method for performing membrane-filtration according to claim 13 , wherein the powdered culture medium is a culture medium for animal cells.

15. The method for performing membrane-filtration according to claim 14 , wherein the powdered culture medium is a culture medium for Chinese hamster ovary tissue-derived CHO cells.

16. The method for performing membrane-filtration according to claim 10 or 11 , wherein the membrane filter used in membrane filtration has a pore size of 1 nm to 100 μm.

17. The method for performing membrane-filtration according to claim 16 , wherein the membrane filter used in membrane filtration has a pore size of 10 nm to 1 μm.

18. The method for performing membrane-filtration according to claim 16 , wherein the membrane filter used in membrane filtration has a pore size of 0.1 μm to 0.5 μm.

Assignments (2)
CHANGE OF NAME AND ADDRESS Recorded Oct 23, 2019
From: KYOWA HAKKO KIRIN CO., LTD.
To: KYOWA KIRIN CO., LTD.
Reel/Frame 050797/0533 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2013
From: KONNO, YOSHINOBU; WAKAMATSU, KAIRO; IMAMOTO, YASUFUMI; ISHIBASHI, JUN; TAKAHASHI, KEN; TANAKA, HISAYA
To: KYOWA HAKKO KIRIN CO., LTD.
Reel/Frame 030697/0204 →